Last reviewed · How we verify

Stoss vitamin D

Murdoch Childrens Research Institute · FDA-approved active Small molecule ✓ Verified May 2026 Quality 0/100

Stoss vitamin D is a Small molecule drug developed by Murdoch Childrens Research Institute. It is currently FDA-approved. Also known as: Stoss cholecalciferol.

Stoss vitamin D is a form of vitamin D3 that has been studied in clinical trials for various conditions, including vitamin D deficiency, atopic dermatitis, and complications from stem cell transplants. It works as a vitamin D receptor agonist, a type of small molecule that activates the vitamin D receptor.

At a glance

Generic nameStoss vitamin D
Also known asStoss cholecalciferol
SponsorMurdoch Childrens Research Institute
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Stoss vitamin D

What is Stoss vitamin D?

Stoss vitamin D is a Small molecule drug developed by Murdoch Childrens Research Institute.

Who makes Stoss vitamin D?

Stoss vitamin D is developed and marketed by Murdoch Childrens Research Institute (see full Murdoch Childrens Research Institute pipeline at /company/murdoch-childrens-research-institute).

Is Stoss vitamin D also known as anything else?

Stoss vitamin D is also known as Stoss cholecalciferol.

What development phase is Stoss vitamin D in?

Stoss vitamin D is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing